This article was originally published Jan. 21.
German service provider GATC Biotech said last week that it has purchased an Illumina HiSeq 2000 sequencer for its Constance laboratory.
The company said in a statement that the new platform, which Illumina launched earlier this month (see In Sequence 1/12/2010), will initially be used for human genome sequencing projects from customers in pharmaceutical and medical research. In addition, GATC plans to offer services on the system to industrial and academic researchers interested in sequencing large eukaryotic genomes.
GATC Biotech CEO Peter Pohl said in a statement that the system, which will complement the firm's three existing Illumina Genome Analyzer IIx sequencers, will be "quickly installed and geared up for production."
The company also has several Roche GS FLX and Applied Biosystems 3730xl sequencers installed, and has been testing Complete Genomics' human genome sequencing service.